OraSure Technologies, Inc. (NASDAQ: OSUR) is a Healthcare company (Medical - Instruments & Supplies) with a market capitalization of $242M. The Maz Rating grades it against the other companies in its sector.
OraSure Technologies, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $3.51, OraSure Technologies, Inc. trades at 2.1x sales and 0.8x book value. Over the last twelve months it generated about $115M of revenue and a net loss of $47M. It runs a gross margin of 41.9%, an operating margin of -40.9% and a net margin of -41.7%. It shows return on equity of -15.2%, return on invested capital of -14.6% and a free cash flow yield of -20.5%. On the balance sheet: a debt-to-equity ratio of 0.04 and a current ratio of 8.58. Over the past 52 weeks the share price ranged from $2.08 to $4.58, with a beta of 1.06.
OraSure Technologies, Inc. does not currently pay a dividend.
13 Wall Street analyst ratings cover the stock: 4 Buy and 9 Hold, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.